172 related articles for article (PubMed ID: 37744450)
1. CCL22 and Leptin associated with steroid resistance in childhood idiopathic nephrotic syndrome.
Zhaoyang P; Wei L; Yanyan J; Wenqing X; Haidong F; Jianhua M
Front Pediatr; 2023; 11():1261034. PubMed ID: 37744450
[TBL] [Abstract][Full Text] [Related]
2. Shared genetic risk across different presentations of gene test-negative idiopathic nephrotic syndrome.
Downie ML; Gupta S; Chan MMY; Sadeghi-Alavijeh O; Cao J; Parekh RS; Diz CB; Bierzynska A; Levine AP; Pepper RJ; Stanescu H; Saleem MA; Kleta R; Bockenhauer D; Koziell AB; Gale DP
Pediatr Nephrol; 2023 Jun; 38(6):1793-1800. PubMed ID: 36357634
[TBL] [Abstract][Full Text] [Related]
3. Urinary cytokines and steroid responsiveness in idiopathic nephrotic syndrome of childhood.
Woroniecki RP; Shatat IF; Supe K; Du Z; Kaskel FJ
Am J Nephrol; 2008; 28(1):83-90. PubMed ID: 17914249
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor 3 (TLR-3), TLR-4 and CD80 expression in peripheral blood mononuclear cells and urinary CD80 levels in children with idiopathic nephrotic syndrome.
Mishra OP; Kumar R; Narayan G; Srivastava P; Abhinay A; Prasad R; Singh A; Batra VV
Pediatr Nephrol; 2017 Aug; 32(8):1355-1361. PubMed ID: 28210837
[TBL] [Abstract][Full Text] [Related]
5. Idiopathic nephrotic syndrome in Syrian children: clinicopathological spectrum, treatment, and outcomes.
Wannous H
Pediatr Nephrol; 2024 Aug; 39(8):2413-2422. PubMed ID: 38587559
[TBL] [Abstract][Full Text] [Related]
6. Follow-up of steroid-resistant nephrotic syndrome: tubular proteinuria and enzymuria.
Vallés P; Peralta M; Carrizo L; Martin L; Principi I; Gonzalez A; Manucha W
Pediatr Nephrol; 2000 Dec; 15(3-4):252-8. PubMed ID: 11149121
[TBL] [Abstract][Full Text] [Related]
7. [Multicenter study on present status of diagnosis and treatment of steroid-resistant nephrotic syndrome in children].
Subspecialty Group Of Nephrology, The Society Of Pediatrics Chinese Medical Association
Zhonghua Er Ke Za Zhi; 2014 Jul; 52(7):483-7. PubMed ID: 25224050
[TBL] [Abstract][Full Text] [Related]
8. Urinary Sediment mRNA Level of CREBBP and CYBA in Children With Steroid-Resistant Nephrotic Syndrome.
Li W; Shou X; Xiang W; He L; Li L; Fu H; Mao J
Front Immunol; 2021; 12():801313. PubMed ID: 35173708
[TBL] [Abstract][Full Text] [Related]
9. Difficult-to-treat idiopathic nephrotic syndrome: established drugs, open questions and future options.
Kemper MJ; Valentin L; van Husen M
Pediatr Nephrol; 2018 Oct; 33(10):1641-1649. PubMed ID: 28879428
[TBL] [Abstract][Full Text] [Related]
10. Second-line immunosuppressive treatment of childhood nephrotic syndrome: a single-center experience.
Kim J; Patnaik N; Chorny N; Frank R; Infante L; Sethna C
Nephron Extra; 2014 Jan; 4(1):8-17. PubMed ID: 24575119
[TBL] [Abstract][Full Text] [Related]
11. Regulatory and effector T cells changes in remission and resistant state of childhood nephrotic syndrome.
Jaiswal A; Prasad N; Agarwal V; Yadav B; Tripathy D; Rai M; Nath M; Sharma RK; Modi DR
Indian J Nephrol; 2014 Nov; 24(6):349-55. PubMed ID: 25484527
[TBL] [Abstract][Full Text] [Related]
12. Clinical Predictors of Steroid Resistance in Childhood Nephrotic Syndrome.
Cicek N; Yıldız N; Guven S; Kaya M; Gokce I; Alpay H
Clin Pediatr (Phila); 2023 Dec; ():99228231219109. PubMed ID: 38142361
[TBL] [Abstract][Full Text] [Related]
13. Precise clinicopathologic findings for application of genetic testing in pediatric kidney transplant recipients with focal segmental glomerulosclerosis/steroid-resistant nephrotic syndrome.
Miura K; Kaneko N; Hashimoto T; Ishizuka K; Shirai Y; Hisano M; Chikamoto H; Akioka Y; Kanda S; Harita Y; Yamamoto T; Hattori M
Pediatr Nephrol; 2023 Feb; 38(2):417-429. PubMed ID: 35655039
[TBL] [Abstract][Full Text] [Related]
14.
Asharam K; Bhimma R; David VA; Coovadia HM; Qulu WP; Naicker T; Gillies CE; Vega-Warner V; Johnson RC; Limou S; Kopp JB; Sampson M; Nelson GW; Winkler CA
Kidney Int Rep; 2018 Nov; 3(6):1354-1362. PubMed ID: 30450462
[TBL] [Abstract][Full Text] [Related]
15. Correlation between Toll-like Receptor Gene Polymorphisms and Idiopathic Nephrotic Syndrome in Chinese Children.
Gao HH; Li W; Shou XY; Mao JH
Curr Med Sci; 2023 Jun; 43(3):585-591. PubMed ID: 37115397
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Outcome of Secondary Steroid-Resistant Nephrotic Syndrome in Chinese Children.
Ying D; Liu W; Chen L; Rong L; Lin Z; Wen S; Zhuang H; Li J; Jiang X
Kidney Int Rep; 2021 Aug; 6(8):2144-2150. PubMed ID: 34386663
[TBL] [Abstract][Full Text] [Related]
17. Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07).
Horinouchi T; Sako M; Nakanishi K; Ishikura K; Ito S; Nakamura H; Oba MS; Nozu K; Iijima K
BMC Nephrol; 2018 Nov; 19(1):302. PubMed ID: 30382824
[TBL] [Abstract][Full Text] [Related]
18. Mutational analysis of NPHS2 and WT1 in frequently relapsing and steroid-dependent nephrotic syndrome.
Gbadegesin R; Hinkes B; Vlangos C; Mucha B; Liu J; Hopcian J; Hildebrandt F
Pediatr Nephrol; 2007 Apr; 22(4):509-13. PubMed ID: 17216259
[TBL] [Abstract][Full Text] [Related]
19. Childhood nephrotic syndrome at the University of Abuja Teaching Hospital, Abuja, Nigeria: a preliminary report supports high steroid responsiveness.
Anigilaje EA; Fashie AP; Ochi C
Sudan J Paediatr; 2019; 19(2):126-139. PubMed ID: 31969741
[TBL] [Abstract][Full Text] [Related]
20. [Mycophenolate mofetil versus cyclosporine A in children with primary refractory nephrotic syndrome].
Geng HY; Ji LN; Chen CY; Tu J; Li HR; Bao R; Lin Y
Zhonghua Er Ke Za Zhi; 2018 Sep; 56(9):651-656. PubMed ID: 30180402
[No Abstract] [Full Text] [Related]
[Next] [New Search]
